Advertisement
Screener

Metagenomi Therapeutics, Inc. (MGX) Pre-Tax Margin

Metagenomi Therapeutics, Inc. (MGX) Pre-Tax Margin

  • 2026-03-31: Pre-Tax Margin -1846.88%.
  • 2025-12-31: Pre-Tax Margin -575.15%.
  • 2025-09-30: Pre-Tax Margin -238.21%.
  • 2025-06-30: Pre-Tax Margin -233.34%.

Complete source-backed pre-tax margin history.

Available history
2023-03-31 to 2026-03-31
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2026-03-31-1846.88%
2025-12-31-575.15%
2025-09-30-238.21%
2025-06-30-233.34%
2025-03-31-604.34%
2024-12-31-255.94%
2024-09-30-181.34%
2024-06-30-64.66%
2024-03-31-225.36%
2023-12-31-133.62%
2023-09-30-150.56%
2023-06-30-98.00%
2023-03-31-160.98%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-12-31-348.77%
2024-12-31-159.81%
2023-12-31-134.57%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Scilex Holding Co (SCLX)United States$0.042B-0.14
LeonaBio, Inc. (LONA)United States$0.047B-0.61
Instil Bio, Inc. (TIL)United States$0.048B-1.73
Tevogen Inc. (TVGN)United States$0.049B
aTYR PHARMA INC (ATYR)United States$0.033B-0.98
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
ImageneBio, Inc. (IMA)United States$0.056B-1.31
Quince Therapeutics, Inc. (QNCX)United States$0.031B
CEL SCI CORP (CVM)United States$0.030B-0.81
BioAtla, Inc. (BCAB)United States$0.058B-0.21